Company profile: i-Lumen
1.1 - Company Overview
Company description
- Provider of a non-invasive, software-based medical device (i-LUMEN System and Therapy) delivering pulsed microcurrent stimulation to treat dry age-related macular degeneration, and of clinical trials (i-SIGHT Clinical Study) for the i-LUMEN AMD device in patients with nonexudative (dry) AMD in the United States.
Products and services
- I-LUMEN System and Therapy: A software-based medical device delivering pulsed microcurrent stimulation to treat dry age-related macular degeneration in nonexudative AMD patients
- Noninvasive AMD Therapy Development: Develops noninvasive therapy for dry age-related macular degeneration, focusing on treatment approaches for patients with nonexudative (dry) AMD
- I-SIGHT Clinical Study: United States-based clinical trials for the i-LUMEN AMD device in patients with nonexudative (dry) AMD, evaluating therapeutic impact of pulsed microcurrent stimulation
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to i-Lumen
Fisher Scientific
HQ: United States
Website
- Description: Provider of laboratory supply and biotechnology products and services for scientific research and clinical laboratory markets, serving pharmaceutical and biotechnology companies, colleges, universities, secondary education, and medical research institutions. Offerings include same-day shipping on essentials and chemicals, greener products and recycling programs, production workflow and compliance support, imaging systems, cell culture media, and gel electrophoresis supplies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fisher Scientific company profile →
Biodex
HQ: United States
Website
- Description: Provider of products and devices for medical imaging, nuclear medicine, and physical medicine, using science and technology to drive treatment innovation and advance patient progress, including solutions addressing balance deficiency and weakness.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biodex company profile →
Bard EP
HQ: United States
Website
- Description: Provider of innovative healthcare products and services focused on disease state management in vascular, urology, and oncology, serving the needs of healthcare providers and patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bard EP company profile →
Scientific Instrument Services
HQ: United States
Website
- Description: Provider of precision mass spectrometry filaments and ion optic assemblies, and distributor of laboratory supplies for mass spectrometers, gas chromatographs, and related scientific laboratory equipment, including its patented Thermal Desorption System.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Scientific Instrument Services company profile →
Integra LifeSciences
HQ: United States
Website
- Description: Provider of integrated medical devices for tissue regeneration, neurosurgery, and surgical instrumentation, including Integra Dermal Regeneration Template, DuraGen Dural Graft Matrix, NeuraGen Nerve Guide, Jarit surgical instruments, SurgiMend collagen matrix, and Codman neurosurgery products such as intracranial monitoring systems and surgical headlights.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Integra LifeSciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for i-Lumen
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to i-Lumen
2.2 - Growth funds investing in similar companies to i-Lumen
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for i-Lumen
4.2 - Public trading comparable groups for i-Lumen
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →